JERICHO, N.Y., July 27, 2026 /PRNewswire/ — FIZE Medical, a company advancing precision fluid management in critical care, today announced it has received CE mark and UKCA certification for its FIZE kUO^® System. This regulatory milestone clears the way for the company to immediately initiate full commercial activities and product distribution across Europe the UK.

The CE Mark and UKCA certification represents another significant milestone in FIZE Medical’s global growth strategy. Together with its established commercial presence in North America and Japan, the company is now positioned to expand its reach across the world’s major healthcare markets.  

“Receiving the CE Mark and UKCA Certification is a pivotal milestone for FIZE Medical,” said Dror Zerem, CEO of FIZE Medical. “It validates the safety, performance, and clinical value of our technology and marks an important step in bringing our solution to hospitals in the EU and the UK. We look forward to partnering with hospitals across Europe and the UK to equip intensive care teams with continuous, real-time digital monitoring that supports precision fluid management, earlier clinical intervention, and better patient outcomes.”